Rational drug design: grid- and ludi-based structural modifications of a human synovial fluid phospholipase A2 inhibitor leading to enhanced activity
M.T. Pisabarro, A. Palomer, A.R. Ortiz, R.C. Wade, F. Gago, D. Mauleón, G. CarganicoVolume:
12
Year:
1994
Language:
english
DOI:
10.1016/0263-7855(94)80054-5
File:
PDF, 128 KB
english, 1994